Identification of tumour initiating cells in feline head and neck squamous cell carcinoma and evidence for gefitinib induced epithelial to mesenchymal transition

Veterinary Journal

Volumn 193, Issue 1, 2012, Pages 46-52

  Pang, L Y ^a   Bergkvist, G T ^a   Cervantes Arias, A ^a   Yool, D A ^a   Muirhead, R ^a   Argyle, D J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cancer stem cell; EMT; Feline squamous cell carcinoma; Gefitinib

Indexed keywords

CD133 ANTIGEN; DOXORUBICIN; FIBRONECTIN; GEFITINIB; MITOXANTRONE; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CAT; CELL INVASION; CELL STRUCTURE; CONTROLLED STUDY; DRUG SENSITIVITY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; RADIOSENSITIVITY;

ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CAT DISEASES; CATS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; GLYCOPROTEINS; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASTIC STEM CELLS; PEPTIDES; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

FELIDAE;

EID: 84863780662     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2012.01.009     Document Type: Article

References (38)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:3983-3988.
2. Argyle D.J., Blacking T. From viruses to cancer stem cells: Dissecting the pathways to malignancy. The Veterinary Journal 2008, 177:311-323.
3. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
4. Bergkvist G.T., Argyle D.J., Pang L.Y., Muirhead R., Yool D.A. Studies on the inhibition of feline EGFR in squamous cell carcinoma enhancement of radiosensitivity and rescue of resistance to small molecule inhibitors. Cancer Biology and Therapy 2011, 11:927-937.
5. Blacking T.M., Waterfall M., Argyle D.J. CD44 is associated with proliferation, rather than a specific cancer stem cell population, in cultured canine cancer cells. Veterinary Immunology and Immunopathology 2011, 141:46-57.
6. Blacking T.M., Wilson H., Argyle D.J. Is cancer a stem cell disease? Theory, evidence and implications. Veterinary and Comparative Oncology 2007, 5:76-89.
7. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 1997, 3:730-737.
8. Christiansen J.J., Rajasekaran A.K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Research 2006, 66:8319-8326.
9. Cohen E.E. Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Journal Clinical Oncology 2006, 24:2659-2665.
10. Dhaliwal R.S., Kufuor-Mensah E. Metastatic squamous cell carcinoma in a cat. Journal of Feline Medical Surgery 2007, 9:61-66.
11. Dobrossy L. Epidemiology of head and neck cancer: Magnitude of the problem. Cancer Metastasis Review 2005, 24:9-17.
12. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Research 2004, 64:7011-7021.
13. Gibbs C.P., Kukekov V.G., Reith J.D., Tchigrinova O., Suslov O.N., Scott E.W., Ghivizzani S.C., Ignatova T.N., Steindler D.A. Stem-like cells in bone sarcomas: Implications for tumorigenesis. Neoplasia 2005, 7:967-976.
14. Gupta P.B., Onder T.T., Jiang G., Tao K., Kuperwasser C., Weinberg R.A., Lander E.S. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138:645-659.
15. Haddad Y., Choi W., McConkey D.J. Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines. Clinical Cancer Research 2009, 15:532-542.
16. Hahn K.A., Frazier D.L., Cox S.K., Legendre A.M. Effect of infusion regime on doxorubicin pharmacokinetics in the cat. Journal of American Animal Hospital Association 1997, 33:427-433.
17. Hayes A.M., Adams V.J., Scase T.J., Murphy S. Survival of 54 cats with oral squamous cell carcinoma in United Kingdom general practice. Journal of Small Animal Practice 2007, 48:394-399.
18. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
19. Iannolo G., Conticello C., Memeo L., De Maria R. Apoptosis in normal and cancer stem cells. Critical Reviews in Oncology Hematology 2008, 66:42-51.
20. Kalyankrishna S., Grandis J.R. Epidermal growth factor receptor biology in head and neck cancer. Journal of Clinical Oncology 2006, 24:2666-2672.
21. Kapatkin A.S., Marretta S.M., Patnaik A.K., Burk R.L., Matus R.E. Mandibular swellings in cats - Prospective-study of 24 cats. Journal of the American Animal Hospital Association 1991, 27:575-580.
22. Kochevar D.T., Middendorf D.L., Mealey K.L., Meyers R.O., Rogers K.S., Barton C.L., Habron L., Alberts D.S., Polzer J.P. Pharmacokinetics and haematological effects of a single intravenous dose of mitoxantrone in cats. Journal of Veterinary Pharmacology and Therapeutics 1995, 18:471-475.
23. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
24. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
25. Pang L.Y., Argyle D.J. Using naturally occurring tumours in dogs and cats to study telomerase and cancer stem cell biology. Biochimica et Biophysica Acta 2009, 1792:380-391.
26. Pang L.Y.C.-A.A., Else R.W., Argyle D.J. Canine mammary cancer stem cells are radio- and chemo-resistant and exhibit an epithelial-mesenchymal transition phenotype. Cancers 2011, 3:1744-1762.
27. Perez-Soler R., Chachoua A., Hammond L.A., Rowinsky E.K., Huberman M., Karp D., Rigas J., Clark G.M., Santabarbara P., Bonomi P. Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer. Journal of Clinical Oncology 2004, 22:3238-3247.
28. Prince M.E., Ailles L.E. Cancer stem cells in head and neck squamous cell cancer. Journal of Clinical Oncology 2008, 26:2871-2875.
29. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:973-978.
30. Reuter C.W., Morgan M.A., Eckardt A. Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck. British Journal of Cancer 2007, 96:408-416.
31. Rizzo S., Attard G., Hudson D.L. Prostate epithelial stem cells. Cell Proliferation 2005, 38:363-374.
32. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Research 2003, 63:5821-5828.
33. Tannehill-Gregg S., Kergosien E., Rosol T.J. Feline head and neck squamous cell carcinoma cell line: Characterization, production of parathyroid hormone-related protein, and regulation by transforming growth factor-beta. In Vitro Cellular and Developmental Biology - Animal 2001, 37:676-683.
34. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Current Opinion in Cell Biology 2003, 15:740-746.
35. Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V., Tsukamoto A.S., Gage F.H., Weissman I.L. Direct isolation of human central nervous system stem cells. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:14720-14725.
36. Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V., Tsukamoto A.S., Gage F.H., Weissman I.L. Direct isolation of human central nervous system stem cells. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:14720-14725.
37. Villa A., Snyder E.Y., Vescovi A., Martinez-Serrano A. Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. Experimental Neurology 2000, 161:67-84.
38. Wilson H., Huelsmeyer M., Chun R., Young K.M., Friedrichs K., Argyle D.J. Isolation and characterisation of cancer stem cells from canine osteosarcoma. The Veterinary Journal 2008, 175:69-75.